Vitality Watch

Dossier biorxiv trial early 10-sep-2026
Small or early-phase human trial or pilot study

Effects of a 12-week unsupervised and adapted physical activity prescription on physical per-formance in geriatric outpatients with overweight or obesity: the PACE tool

Key claim: A 12-week unsupervised adapted home-based physical activity prescription (PACE) achieved high adherence and improved lower-limb muscle function and endurance while reducing probable sarcopenia prevalence in overweight/obese frail geriatric outpatients.

Abstract

BackgroundSarcopenia and obesity often coexist in older adults and are associated with higher functional decline, disability, and reduced quality of life. Although physical activity (PA) is protective, prescription and adherence to exercise programs remains low in this population. Pragmatic and scalable interventions are therefore needed. Thus, we evaluated the effects of a 12-week unsupervised PA prescription program on physical performance in overweight/obese frail geriatric outpatients.

MethodsA single-arm interventional study was conducted among geriatric outpatients aged [≥]60 years. Thirty-seven overweight/obese participants (20 women) completed the 12-week home-based PACE prescription which included individualized functional and resistance exercises with walking. Physical performance [i.e. functional capacity (SPPB), walking speed, Timed Up and Go (TUG), lower-limb muscle endurance (30-STS) and function (5-STS)], clinical status (probable sarcopenia, fall risk, walking speed) and clinically meaningful changes were assessed.

ResultsParticipants achieved 238 {+/-} 140 min/week of PA on average, with 65% meeting recommended PA guidelines. Significant improvements were observed in lower-limb muscle function (p=0.033) and endurance (p=0.006) and in absolute (p=0.038) or relative (p=0.045) estimated muscle power. The prevalence of probable sarcopenia decreased significantly following the intervention (p=0.011). Clinically meaningful improvements were observed in muscle endurance (p<0.001) and functional status (p=0.040).

ConclusionIn overweight/obese frail geriatric outpatients, the prescription of PACE achieved high PA adherence and improved lower-limb muscle function. Integrating this pragmatic and personalized PA strategy into routine geriatric care may support healthy aging and help prevent sarcopenia-obesity related functional decline.

Key pointsO_LIA 12-week unsupervised and adapted PA prescription (PACE tool) is feasible in frail geriatric outpatients with overweight or obesity. C_LIO_LIHigh adherence was achieved, with 65% of participants meeting or exceeding PA recommendations, alongside significant improvements observed in lower-limb muscle function (power and endurance). C_LIO_LIThe intervention led to a clinically meaningful reduction in probable sarcopenia prevalence. C_LIO_LIPACE could represent a pragmatic and scalable strategy to improve functional outcomes in overweight/obese geriatric population. C_LI

Why this matters

Most sarcopenia and frailty exercise evidence in this area comes from supervised clinic-based or protocolized RCTs; PACE tests whether a written, adapted prescription executed unsupervised at home can still move lower-limb function and sarcopenia status in a hard-to-reach overweight/obese geriatric outpatient group. As an uncontrolled single-arm study it cannot separate the prescription from regression-to-the-mean or attention effects, but it adds a pragmatic-delivery data point to a literature dominated by supervised programs.

Source

Link

Briefing card

Effects of a 12-week unsupervised and adapted physical activity prescription on physical per-formance in geriatric outpatients with overweight or obesity: the PACE tool
Stage: trial early · biorxiv · 10-sep-2026

If you are a frail overweight or obese older outpatient given a written home exercise prescription, this uncontrolled trial found participants adhered to it and gained lower-limb function over 12 weeks — but with no control group, the size of the true intervention effect is unresolved.

A 12-week unsupervised adapted home-based physical activity prescription (PACE) achieved high adherence and improved lower-limb muscle function and endurance while reducing probable sarcopenia prevalence in overweight/obese frail geriatric outpatients.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.64898/2026.09.06.26359363

build build 880 · 2bcef25 · 2026-11-18